DCMIC
SLRN

Decheng Capital Management III (Cayman)’s ACELYRIN SLRN Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$15.7M Sell
1,548,317
-6,100
-0.4% -$130K 5.26% 5
2023
Q2 		$32.5M Buy
+1,554,417
New +$31.8M 10.19% 3

Other funds holding SLRN

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Decheng Capital Management III (Cayman)'s SLRN Position: Q3 2023 in Review

Decheng Capital Management III (Cayman) reduced its ACELYRIN (SLRN) stake by 0.39% in Q3 2023, selling an estimated $130K and leaving 1,548,317 shares worth $15.7M. The position accounts for 5.26% of the portfolio, ranked #5.

Decheng Capital Management III (Cayman) first reported a position in SLRN in Q2 2023 and has held it in 2 quarters since. The position peaked at $32.5M in Q2 2023. 101 funds tracked by Wall St. Rank hold SLRN as of Q3 2023.

  • Decheng Capital Management III (Cayman) held 1,548,317 shares of ACELYRIN worth $15.7M as of Q3 2023.
  • Decheng Capital Management III (Cayman) sold 6,100 ACELYRIN shares in Q3 2023, an estimated $130K.
  • ACELYRIN made up 5.26% of Decheng Capital Management III (Cayman)'s portfolio in Q3 2023, its #5 holding.
  • Decheng Capital Management III (Cayman) first reported a position in ACELYRIN in Q2 2023 and has held it in 2 quarters since.
  • Decheng Capital Management III (Cayman)'s ACELYRIN position peaked at $32.5M in Q2 2023.
  • 101 funds tracked by Wall St. Rank held ACELYRIN as of Q3 2023.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q3 2023, filed 13 Nov 2023.